Hexarelin

Hexarelin Product Description — Research Use Only

Hexarelin is a synthetic research peptide classified as a growth hormone secretagogue. It is commonly studied for growth hormone signaling, pituitary response, ghrelin/GHSR receptor activity, IGF-1 pathway research, metabolic function, appetite-related signaling, and cardiovascular-response pathways.

Research on Hexarelin has most commonly focused on growth hormone release, pituitary signaling, GHSR/ghrelin-receptor activity, IGF-1-related pathways, cardiac-response research, energy balance, and body-composition markers. Published studies describe Hexarelin as a synthetic growth hormone-releasing peptide that can activate growth hormone secretagogue receptor pathways involved in GH release and related endocrine signaling.

Hexarelin is commonly studied for:

• Growth hormone signaling — how the pituitary releases growth hormone

• Pituitary response — how the pituitary reacts to GH-releasing signals

• Ghrelin-receptor activity — how Hexarelin interacts with GHSR-related pathways

• IGF-1 pathways — how GH signaling may influence IGF-1-related activity

• Metabolic research — how energy use and fuel balance are studied

• Body-composition research — markers related to lean mass, fat mass, and energy balance

• Cardiac-response pathways — how heart-related tissues respond to stress or protective signaling

Hexarelin is commonly studied because it acts as a growth hormone secretagogue, meaning it is researched for its ability to stimulate GH release rather than supply GH directly. Research has also explored Hexarelin in cardiac-response models, with studies investigating its effects on ventricular function, ischemia-related stress response, and cardiovascular signaling pathways.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.